Literature DB >> 7306432

The effect of level of depression on the use of visual analogue scales by normal volunteers.

M Peet, S Ellis, R A Yates.   

Abstract

1 In two separate studies, 102 normal male volunteers were screened for level of depression using the Zung Self-Rating Depression Scale (Zung, 1965). Eight high scorers and eight low scorers were selected for inclusion in each study. 2 There were marked differences in scores on the visual analogue mood scales of Bond & Lader (1974) between the high depressed (HD) and low depressed (LD) groups. 3 In the first study, subjects were given single doses of imipramine 50 mg and 100 mg, diazepam 10 mg, and placebo in a double-blind randomized crossover design with 1 week between treatments. Drug effects as assessed on visual analogue scales were significantly more marked in the LD than in the HD group, to the extent that the sedative effects of imipramine 50 mg and diazepam 10 mg were minimal or absent in the HD groups whereas these effects were clear and highly significant in the LD group. 4 In a second study, LD and HD volunteers were given more objective items to rate using visual analogue scales. Ratings of the size of each of a series of ten circles, and of the weight of a 'black box', were consistently and significantly lower in the LD than in the HD group. Significant differences between LD and HD groups were also found on a series of visual analogue scales expressing attitudes not directly related to mood. 5 It is concluded that normal volunteers with varying levels of depression cannot be considered as homogeneous in their mode of expression on visual analogue scales, and that this should be taken into account in the design and interpretation of studies involving the use of such scales.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306432      PMCID: PMC1401874          DOI: 10.1111/j.1365-2125.1981.tb01197.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Relationships between effects of a number of centrally acting drugs and personality.

Authors:  C KORNETSKY; O HUMPHRIES
Journal:  AMA Arch Neurol Psychiatry       Date:  1957-03

2.  Psychiatric evaluation of normal control volunteers.

Authors:  W POLLIN; S PERLIN
Journal:  Am J Psychiatry       Date:  1958-08       Impact factor: 18.112

3.  The volunteer subject in research.

Authors:  L LASAGNA; J M VON FELSINGER
Journal:  Science       Date:  1954-09-03       Impact factor: 47.728

4.  Effects of antianxiety drug and personality on stress-inducing psychomotor performance test.

Authors:  S Nakano; N Ogawa; Y Kawazu; E Osato
Journal:  J Clin Pharmacol       Date:  1978 Feb-Mar       Impact factor: 3.126

5.  Effect of alcohol and benzodiazepines on performance as related to personality characteristics. Personality characteristics among healthy "placebo reactors" and nonreactors.

Authors:  M Linnoila; R Liljequist; J Olkoniemi; I Saario
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1977-07

6.  Motivations and rewards for volunteering to be an experimental subject.

Authors:  F J Ayd; P Calabresi
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

7.  Prevalence of depression over a 12-month period in a nonpatient population.

Authors:  J Barrett; M W Hurst; C DiScala; R M Rose
Journal:  Arch Gen Psychiatry       Date:  1978-06

8.  Measuring depressive symptomatology in a general population.

Authors:  M D Blumenthal
Journal:  Arch Gen Psychiatry       Date:  1975-08

9.  Comparative effects on anxiety of the "minor tranquilizers" in "high" and "low" anxious student volunteers.

Authors:  J E Barrett; A DiMascio
Journal:  Dis Nerv Syst       Date:  1966-07

10.  Influence of neuroticism on oral absorption of diazepam.

Authors:  S Nakano; N Ogawa; Y Kawazu
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

View more
  1 in total

1.  Monoamine oxidase inhibition by tranylcypromine: assessment in human volunteers.

Authors:  P R Bieck; K H Antonin
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.